A detailed history of Aull & Monroe Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 15,868 shares of ABT stock, worth $1.84 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
15,868
Previous 16,468 3.64%
Holding current value
$1.84 Million
Previous $1.71 Million 5.73%
% of portfolio
0.85%
Previous 0.85%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$100.07 - $118.13 $60,041 - $70,878
-600 Reduced 3.64%
15,868 $1.81 Million
Q2 2024

Jul 19, 2024

SELL
$100.73 - $112.44 $266,934 - $297,966
-2,650 Reduced 13.86%
16,468 $1.71 Million
Q1 2024

May 06, 2024

SELL
$109.52 - $120.96 $47,422 - $52,375
-433 Reduced 2.21%
19,118 $2.17 Million
Q4 2023

Jan 25, 2024

SELL
$90.19 - $110.4 $49,875 - $61,051
-553 Reduced 2.75%
19,551 $2.15 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $44,994 - $53,986
-471 Reduced 2.29%
20,104 $1.95 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $91,048 - $107,169
-940 Reduced 4.37%
20,575 $2.08 Million
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $52,663 - $61,782
-554 Reduced 2.51%
21,515 $2.36 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $10,819 - $13,077
-106 Reduced 0.48%
22,069 $2.4 Million
Q1 2022

May 02, 2022

SELL
$114.02 - $139.04 $22,804 - $27,808
-200 Reduced 0.89%
22,175 $2.63 Million
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $24,723 - $30,272
-214 Reduced 0.95%
22,375 $3.15 Million
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $1,166 - $1,290
-10 Reduced 0.04%
22,589 $2.67 Million
Q1 2021

Apr 19, 2021

SELL
$108.84 - $128.23 $21,768 - $25,645
-200 Reduced 0.88%
22,599 $2.71 Million
Q4 2020

Feb 02, 2021

SELL
$105.0 - $114.42 $6,825 - $7,437
-65 Reduced 0.28%
22,799 $2.5 Million
Q3 2020

Nov 02, 2020

SELL
$91.64 - $111.29 $9,164 - $11,129
-100 Reduced 0.44%
22,864 $2.49 Million
Q2 2020

Jul 28, 2020

SELL
$76.57 - $98.0 $155,207 - $198,646
-2,027 Reduced 8.11%
22,964 $2.1 Million
Q4 2019

Feb 04, 2020

SELL
$78.51 - $87.4 $62,808 - $69,920
-800 Reduced 3.1%
24,991 $2.17 Million
Q3 2019

Oct 30, 2019

SELL
$81.84 - $88.74 $101,481 - $110,037
-1,240 Reduced 4.59%
25,791 $2.16 Million
Q2 2019

Jul 29, 2019

SELL
$72.88 - $85.0 $21,864 - $25,500
-300 Reduced 1.1%
27,031 $2.27 Million
Q1 2019

Apr 18, 2019

SELL
$66.22 - $80.06 $79,464 - $96,072
-1,200 Reduced 4.21%
27,331 $2.19 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $127,842 - $144,826
-1,950 Reduced 6.4%
28,531 $2.06 Million
Q3 2018

Oct 31, 2018

SELL
$60.81 - $73.36 $24,324 - $29,344
-400 Reduced 1.3%
30,481 $2.24 Million
Q2 2018

Jul 24, 2018

SELL
$57.57 - $63.54 $25,906 - $28,593
-450 Reduced 1.44%
30,881 $1.88 Million
Q1 2018

May 10, 2018

SELL
$56.27 - $63.62 $16,881 - $19,086
-300 Reduced 0.95%
31,331 $1.88 Million
Q4 2017

Jan 29, 2018

SELL
$53.68 - $57.47 $31,134 - $33,332
-580 Reduced 1.8%
31,631 $1.81 Million
Q3 2017

Oct 26, 2017

SELL
$48.06 - $53.64 $9,612 - $10,728
-200 Reduced 0.62%
32,211 $1.72 Million
Q2 2017

Aug 14, 2017

BUY
N/A
32,411
32,411 $1.58 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aull & Monroe Investment Management Corp Portfolio

Follow Aull & Monroe Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.